About ETIHX
The Eventide Healthcare & Life Sciences Fund is an open-end mutual fund that focuses on investing in equity and equity-related securities of companies operating within the healthcare and life sciences sectors. Its primary objective is to achieve long-term capital appreciation by targeting businesses that derive a significant portion of their revenue from activities such as biotechnology, pharmaceuticals, diagnostics, medical devices, healthcare information technology, and life science tools. The fund follows a values-based investment approach, emphasizing companies with ethical and sustainable business practices and often avoiding short-term speculative trends in favor of firms developing impactful products like medicines, treatments, and enabling technologies.
The portfolio typically commits at least 80% of its net assets to stocks, options, preferred shares, and convertible debt within healthcare and related fields, and may include investments in both domestic and international companies, including those at various stages of development or with illiquid securities. A notable portion of assets, approximately 42%, is often concentrated in its top ten holdings, reflecting active management and focused sector bets. The fund’s role in the market is to provide targeted exposure to the innovative and evolving healthcare and life sciences industries, serving institutional and high-net-worth investors seeking a specialized strategy within this essential economic sector.
Fund Family Eventide Funds
Category Health
Performance Rating Average
Risk Rating High
Stock Exchange Nasdaq
Ticker Symbol ETIHX
Share Class Class I Shares
Index S&P Biotechnology Select Industry TR
ETIHX had a total return of 16.84% in the past year, including dividends. Since the fund's
inception, the average annual return has been 14.21%.
